Novo Nordisk, the Danish pharmaceutical giant behind blockbuster weight-loss drugs Ozempic and Wegovy, has confirmed a cybersecurity breach involving unauthorized access to sensitive clinical data and internal artificial intelligence (AI) assets. The company disclosed that attackers successfully exfiltrated a limited volume of non-public information, raising concerns over data security within highly regulated healthcare and research […] The post Novo Nordisk Confirms Cyberattack Exposing Patient Medical Data and Internal AI Assets appeared first on GBHackers Security | #1 Globally Trusted Cyber Security News Platform.
First seen on gbhackers.com
Jump to article: gbhackers.com/novo-nordisk-confirms-cyberattack-exposing-patient-medical-data/
